Best practice in HRRm testing in patients with metastatic prostate cancer

ASCO 2024: Advances in NSCLC

Looking at real world evidence on PSA testing in prostate cancer

Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI

ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus

Global trends and inequalities in breast cancer survival and care

Multiple myeloma in a resource constrained setting

Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems

Stockholm3 offers a promising avenue for personalised risk-based prostate cancer diagnosis

Baseline characteristics of patients with PSMA-PET–positive and –negative disease with high-risk BCR after radical RP

Gastro-intestinal endoscopy capacity in Nigeria: strengths and challenges

Colorectal cancer risk factors in Nigeria